Leiter, L. A., Cariou, B., Müller‐Wieland, D., Colhoun, H. M., Del Prato, S., Tinahones, F. J., . . . Henry, R. R. (2017). Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial. Diabetes Obes Metab.
Dyfyniad Arddull ChicagoLeiter, Lawrence A., et al. "Efficacy and Safety of Alirocumab in Insulin‐treated Individuals With Type 1 or Type 2 Diabetes and High Cardiovascular Risk: The ODYSSEY DM‐INSULIN Randomized Trial." Diabetes Obes Metab 2017.
Dyfyniad MLALeiter, Lawrence A., et al. "Efficacy and Safety of Alirocumab in Insulin‐treated Individuals With Type 1 or Type 2 Diabetes and High Cardiovascular Risk: The ODYSSEY DM‐INSULIN Randomized Trial." Diabetes Obes Metab 2017.